China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)
China
· Delayed Price · Currency is CNY 41.88
+0.84 (2.05%)
Mar 14, 2025, 2:45 PM CST
SHE:000999 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 27,617 | 23,837 | 17,411 | 14,825 | 13,093 | Upgrade
|
| Other Revenue | - | 901.47 | 667.99 | 719.33 | 544.28 | Upgrade
|
| Revenue | 27,617 | 24,739 | 18,079 | 15,544 | 13,637 | Upgrade
|
| Revenue Growth (YoY) | 11.63% | 36.83% | 16.31% | 13.98% | -7.82% | Upgrade
|
| Cost of Revenue | 13,296 | 11,726 | 8,354 | 6,561 | 5,143 | Upgrade
|
| Gross Profit | 14,321 | 13,013 | 9,725 | 8,984 | 8,494 | Upgrade
|
| Selling, General & Admin | 8,878 | 8,489 | 6,135 | 5,992 | 5,947 | Upgrade
|
| Research & Development | 801.75 | 714.5 | 593.94 | 560.2 | 459.84 | Upgrade
|
| Other Operating Expenses | 5.07 | 262.72 | 207.05 | 204.39 | 175.49 | Upgrade
|
| Operating Expenses | 9,779 | 9,521 | 6,942 | 6,770 | 6,602 | Upgrade
|
| Operating Income | 4,542 | 3,492 | 2,784 | 2,214 | 1,892 | Upgrade
|
| Interest Expense | -80.04 | -80.78 | -21.23 | -14.18 | -5.09 | Upgrade
|
| Interest & Investment Income | 133.9 | 125.1 | 118.11 | 101.08 | 156.22 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.5 | -56.25 | -12.89 | -9.68 | Upgrade
|
| Other Non Operating Income (Expenses) | 120.03 | -17.44 | -4.11 | -1.11 | -21.91 | Upgrade
|
| EBT Excluding Unusual Items | 4,716 | 3,521 | 2,820 | 2,287 | 2,012 | Upgrade
|
| Impairment of Goodwill | - | - | -65.51 | -44.24 | -174.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.39 | -28.63 | 2.58 | 5.04 | 6.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 31.43 | 0.81 | 2.28 | 0.85 | -2.69 | Upgrade
|
| Asset Writedown | -163.29 | -31.48 | -34.3 | -8.1 | -7.95 | Upgrade
|
| Other Unusual Items | - | 292.43 | 237.69 | 202.96 | 225.89 | Upgrade
|
| Pretax Income | 4,594 | 3,754 | 2,963 | 2,444 | 2,059 | Upgrade
|
| Income Tax Expense | 815.87 | 580.97 | 466.43 | 345.41 | 441.89 | Upgrade
|
| Earnings From Continuing Operations | 3,778 | 3,173 | 2,497 | 2,099 | 1,618 | Upgrade
|
| Minority Interest in Earnings | -409.85 | -320.55 | -48.21 | -43.49 | -20.04 | Upgrade
|
| Net Income | 3,368 | 2,853 | 2,449 | 2,055 | 1,597 | Upgrade
|
| Net Income to Common | 3,368 | 2,853 | 2,449 | 2,055 | 1,597 | Upgrade
|
| Net Income Growth | 18.05% | 16.50% | 19.16% | 28.65% | -23.89% | Upgrade
|
| Shares Outstanding (Basic) | 1,281 | 1,279 | 1,284 | 1,272 | 1,274 | Upgrade
|
| Shares Outstanding (Diluted) | 1,281 | 1,279 | 1,284 | 1,272 | 1,274 | Upgrade
|
| Shares Change (YoY) | 0.13% | -0.37% | 0.90% | -0.15% | -0.07% | Upgrade
|
| EPS (Basic) | 2.63 | 2.23 | 1.91 | 1.62 | 1.25 | Upgrade
|
| EPS (Diluted) | 2.63 | 2.23 | 1.91 | 1.62 | 1.25 | Upgrade
|
| EPS Growth | 17.89% | 16.94% | 18.09% | 28.84% | -23.84% | Upgrade
|
| Free Cash Flow | 3,612 | 3,335 | 2,055 | 1,012 | 1,602 | Upgrade
|
| Free Cash Flow Per Share | 2.82 | 2.61 | 1.60 | 0.80 | 1.26 | Upgrade
|
| Dividend Per Share | - | 1.154 | 0.769 | 0.656 | 0.385 | Upgrade
|
| Dividend Growth | - | 50.00% | 17.26% | 70.57% | 16.26% | Upgrade
|
| Gross Margin | 51.86% | 52.60% | 53.79% | 57.79% | 62.28% | Upgrade
|
| Operating Margin | 16.45% | 14.12% | 15.40% | 14.24% | 13.87% | Upgrade
|
| Profit Margin | 12.20% | 11.53% | 13.54% | 13.22% | 11.71% | Upgrade
|
| Free Cash Flow Margin | 13.08% | 13.48% | 11.37% | 6.51% | 11.75% | Upgrade
|
| EBITDA | 5,295 | 4,178 | 3,251 | 2,643 | 2,282 | Upgrade
|
| EBITDA Margin | 19.17% | 16.89% | 17.98% | 17.00% | 16.73% | Upgrade
|
| D&A For EBITDA | 753.09 | 685.71 | 467.17 | 429.17 | 390.19 | Upgrade
|
| EBIT | 4,542 | 3,492 | 2,784 | 2,214 | 1,892 | Upgrade
|
| EBIT Margin | 16.45% | 14.12% | 15.40% | 14.24% | 13.87% | Upgrade
|
| Effective Tax Rate | 17.76% | 15.47% | 15.74% | 14.13% | 21.46% | Upgrade
|
| Revenue as Reported | - | 24,739 | 18,079 | 15,544 | 13,637 | Upgrade
|
| Advertising Expenses | - | 660.33 | 543.92 | 578.72 | 446.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.